Webb1 feb. 2024 · Using a technique called Multiplexed Identification of T-cell Receptor Antigen specificity (MIRA), we input hundreds of antigens of interest, including tumor-associated antigens, viral antigens and neoantigens, and identify thousands of TCRs to these antigens. WebbSharon Benzeno - Adaptive Biotechnologies Corp. Cancer Neoantigen Vaccines Speaker Sharon Benzeno Chief Commercial Officer, Immune Medicine at Adaptive …
Sharon Benzeno, PhD - Adaptive Biotech
WebbADPT - key executives, insider trading, ownership, revenue and average growth rates. Detailed company description & address for Adaptive Biotechnologies Corp.. WebbDr. Sharon Benzeno is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial-stage biotech company that … twitch index
Sharon Benzeno, PhD, MBA The Conference Forum
WebbSharon Benzeno is a Chief Business Development Officer. Dr. Benzeno has 15 years of biopharmaceutical experience in oncology, therapeutics, R&D and M&A. Prior to joining … WebbDr. Sharon Benzeno is the Chief Commercial Officer, Immune Medicine and leads the Drug Discovery group of Adaptive Biotechnologies, a commercial stage biotech company that … WebbPublic asset : 221,505 USD Linked companies : Adaptive Biotechnologies Corporation Summary Katey Owen is on the board of The End Fund and Adaptive Biotechnologies Corp. and Director-Neglected Tropical Diseases at Bill & Melinda Gates Foundation Trust. She received a doctorate from Purdue University. Current positions of Katey Owen twitch india discord